Biostock makes a video interview with CSO, professor Magnus Essand, on the iTANK, publication.

April 6, 2022

Elicera Therapeutics recently announced the publication of a scientific article describing the mechanism-of-action of its universal CAR T-cell enhancement technology platform iTANK. The publication came in Nature Biomedical Engineering, one of the highest ranked scientific journals in the world. CSO and co-founder Professor Magnus Essand joined BioStock Studio via link from Uppsala to tell us more about iTANK and the importance of this publication.

Download attachment (pdf)
< Back to press releases